A Phase 1 Study to Investigate the Safety and Pharmacokinetics of ABBV-CLS-7262 in Patients With Amyotrophic Lateral Sclerosis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04948645 |
|
Recruitment Status :
Active, not recruiting
First Posted : July 2, 2021
Last Update Posted : January 25, 2023
|
Sponsor:
Calico Life Sciences LLC
Collaborator:
AbbVie
Information provided by (Responsible Party):
Calico Life Sciences LLC
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | January 12, 2023 |
| Estimated Study Completion Date : | December 2025 |